Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 159 participants.
Also called NCT01190007
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 159 participants
- Registry
-
NCT01190007
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01190007. Non-randomized; no masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2012-02 (actual). Results posted on 2012-12-03.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients
- Condition
- Hypertension
- Condition
- Hypercholesterolemia
- Condition
- Angina Pectoris
- Intervention (Drug)
- Caduet
- Lead sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Record details
- Record id
cardio:ct-nct01190007- Content hash
40e25c4a446ae813a299d527bfe030d24b2f9c92ecbf3255246a5f429b145721